Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sudhir Srivastava is active.

Publication


Featured researches published by Sudhir Srivastava.


Journal of Alzheimer's Disease | 2015

Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?

Avijit Banik; Richard E. Brown; James R. Bamburg; Debomoy K. Lahiri; Dheeraj Khurana; Robert P. Friedland; Wei Chen; Ying Ding; Amritpal Mudher; Ante L. Padjen; Elizabeta B. Mukaetova-Ladinska; Masafumi Ihara; Sudhir Srivastava; M.V. Padma Srivastava; Colin L. Masters; Raj N. Kalaria; Akshay Anand

Preclinical studies are essential for translation to disease treatments and effective use in clinical practice. An undue emphasis on single approaches to Alzheimers disease (AD) appears to have retarded the pace of translation in the field, and there is much frustration in the public about the lack of an effective treatment. We critically reviewed past literature (1990-2014), analyzed numerous data, and discussed key issues at a consensus conference on Brain Ageing and Dementia to identify and overcome roadblocks in studies intended for translation. We highlight various factors that influence the translation of preclinical research and highlight specific preclinical strategies that have failed to demonstrate efficacy in clinical trials. The field has been hindered by the domination of the amyloid hypothesis in AD pathogenesis while the causative pathways in disease pathology are widely considered to be multifactorial. Understanding the causative events and mechanisms in the pathogenesis are equally important for translation. Greater efforts are necessary to fill in the gaps and overcome a variety of confounds in the generation, study design, testing, and evaluation of animal models and the application to future novel anti-dementia drug trials. A greater variety of potential disease mechanisms must be entertained to enhance progress.


european symposium on computer modeling and simulation | 2009

Wavelet Based Robust Digital Watermarking Technique Using Reverse Additive Algorithm (RAA)

Satish K. Singh; Shishir Kumar; Madhur Srivastava; Amar V. Chandra; Sudhir Srivastava

There are available several watermarking techniques used for data security. Digital media normally assures fairly high quality, nevertheless can be easily reproduced in a perfect form. This perfect reproducibility takes an advantage from certain point of view, while it produces an essential disadvantage, since digital media is frequently copied illegally. A solution of this problem is to embed digital watermark that is not perceived clearly by usual people, but represent the proper right of original product. In this paper a Novel DWT based watermarking technique has been proposed and implemented using MATLAB .This technique shows better performance with respect to robustness and reliability than other existing technique.


Archive | 2000

Method of treating a cognitive memory dysfunction using Gugulipid

Ram Pratap; Raghwendra Pal; Satyawan Singh; Girja Shankar; Chandeshwar Nath; Hemant Kumar Singh; Depak Raina; Arwind Kumar Srivastava; Anil Kumar Rastogi; Puvvada Sri Ramachandra Murthy; Sudhir Srivastava; Onkar Prasad Asthana; Narenda Singh; Nitya Nand


Archive | 2006

An extract from xylocarpus useful for the treatment of diabetes and dyslipidemia

Vijai Lakshmi; Ajet Saxena; Rajesh Kumar; Raghwendra Pal; Satyawan Singh; Arvind K. Srivastava; Preeti Tiwari; Deepak Raina; Anil Kumar Rastogi; Sudhir Srivastava; Mahendra Nath Srivastava; Ramesh Chandra; Anju Puri; Ram Raghubir; Poonam Gupta; Narender Tadigoppula; Brijendra Kumar Tripathi


Archive | 2005

Combination kit used in the treatment of malaria

Francis Joseph Pinto; Swati Ajay Piramal; Ram Pratap; Amiya Prasad Bhaduri; Harsh Pati Thapliyal; Sunil Kumar Puri; G. P. Dutta; Anil Kumar Dwivedi; Satyawan Singh; Pratima Srivastava; V. C. Pandey; Sudhir Srivastava; Shio Kumar Singh; Ram Chandra Gupta; Jagdishwar Sahai Srivastava; Omkar Prasad Asthana


Archive | 1999

METHOD FOR THE TREATMENT OF MALARIA BY THE USE OF PRIMAQUINE DERIVATIVE N1-(3-ETHYLIDINOTETRAHYDROFURAN-2-ONE) -N 4-(6-METHOXY-8-QUINOLINYL)-1,4-PENTANEDIAMINE AS GAMETOCYTOCIDAL AGENT

Ram Pratap; A. P. Bhaduri; Harsh Pati Thapliyal; Sunil K. Puri; G.P. Dutta; Anil Kumar Dwivedi; Satyawan Singh; Pratima Srivastava; V.C. Pandey; Sudhir Srivastava; Shio Kumar Singh; Ram Chandra Gupta; Jagdishwar Sahai Srivastava; Omkar Prasad Asthana


Archive | 2006

Pharmaceutical composition for treatment of diabetes and dyslipidemia

Vijai Lakshmi; Ajet Saxena; Rajesh Kumar; Raghwendra Pal; Satyawan Singh; Arvind K. Srivastava; Preeti Tiwari; Deepak Raina; Anil Kumar Rastogi; Mahendra Nath Srivastava; Ramesh Chandra; Anju Puri; Ram Raghubir; Poonam Gupta; Narender Tadigoppula; Brijendra Kumar Tripathi; Sudhir Srivastava


Archive | 2000

Inclusion complees of a high potent opioid peptide, pharmaceutical compositions and method of treatment

Anil Kumar Dwivedi; Madhu Khanna; Wahajul Haq; Ram Raghubir; Sudhir Srivastava; Puvvada Sri Ramchandra Murthy; Onkar Prasad Asthana; Jagdishwar Sahay Srivastava; Satyawan Singh


Archive | 2000

A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält

Francis Joseph Pinto; Swati Ajay Piramal; Ram Pratap; A. P. Bhaduri; Harsh Pati Thapliyal; Sunil K. Puri; G.P. Dutta; Anil Kumar Dwivedi; Satyawan Singh; Pratima Srivastava; V.C. Pandey; Sudhir Srivastava; Shio Kumar Singh; Ram Chandra Gupta; Jagdishwar Sahai Srivastava; Omkar Prasad Asthana


Archive | 2000

Novel uses of gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions

Ram Pratap; Raghwendra Pal; Satyawan Singh; Girja Shankar; Chandeshwar Nath; Hemant K. Singh; Depak Raina; Arwind Kumar Srivastava; Anil Kumar Rastogi; Puvvada Sri Ramachandra Murthy; Sudhir Srivastava; Onkar Prasad Asthana; Narendra Singh; Nitya Nand

Collaboration


Dive into the Sudhir Srivastava's collaboration.

Top Co-Authors

Avatar

Satyawan Singh

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Ram Pratap

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Anil Kumar Dwivedi

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Harsh Pati Thapliyal

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

Jagdishwar Sahai Srivastava

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

Omkar Prasad Asthana

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Pratima Srivastava

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Ram Chandra Gupta

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Shio Kumar Singh

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

A. P. Bhaduri

Central Drug Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge